Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study. [electronic resource]

By:

Sonneveld, P

Contributor(s):

Marie, J P
Huisman, C
Vekhoff, A
Schoester, M
Faussat, A M
van Kapel, J
Groenewegen, A
Charnick, S
Zittoun, R
Löwenberg, B

Producer: 19961203Description: 1741-50 p. digitalISSN:

0887-6924

Subject(s):

ATP Binding Cassette Transporter, Subfamily B, Member 1 -- biosynthesis
Administration, Oral
Aged
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Cohort Studies
Cyclosporins -- administration & dosage
Dexamethasone -- administration & dosage
Doxorubicin -- administration & dosage
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Multiple Myeloma -- drug therapy
Vincristine -- administration & dosage

In: Leukemia vol. 10

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article

There are no comments on this title.

Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.

APA

Sonneveld P., Marie J. P., Huisman C., Vekhoff A., Schoester M., Faussat A. M., van Kapel J., Groenewegen A., Charnick S., Zittoun R. & Löwenberg B. (19961203). Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study. : Leukemia.

Chicago

Sonneveld P, Marie J P, Huisman C, Vekhoff A, Schoester M, Faussat A M, van Kapel J, Groenewegen A, Charnick S, Zittoun R and Löwenberg B. 19961203. Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study. : Leukemia.

Harvard

Sonneveld P., Marie J. P., Huisman C., Vekhoff A., Schoester M., Faussat A. M., van Kapel J., Groenewegen A., Charnick S., Zittoun R. and Löwenberg B. (19961203). Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study. : Leukemia.

MLA

Sonneveld P, Marie J P, Huisman C, Vekhoff A, Schoester M, Faussat A M, van Kapel J, Groenewegen A, Charnick S, Zittoun R and Löwenberg B. Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study. : Leukemia. 19961203.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC